ANVS - CIK 0001477845
Annovis Bio, Inc. trades as ANVS. This page tracks Annovis Bio, Inc. through 297 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-21 |
| Major company event | 8-K | 2026-05-20 |
| Prospectus supplement | 424B5 | 2026-05-20 |
| Prospectus supplement | 424B5 | 2026-05-19 |
| Quarterly report | 10-Q | 2026-05-15 |
| Major company event | 8-K | 2026-05-15 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
The largest companies sharing Annovis Bio, Inc.'s SEC industry classification (pharmaceutical preparations).
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.